Treatment of Restenosis with a Paclitaxel-Coated Balloon Catheter
To the Editor: We question the conclusion by Scheller and colleagues (Nov. 16 issue) 1 that paclitaxel-coated balloon catheters significantly reduce the incidence of adverse outcomes in patients undergoing percutaneous coronary intervention for in-stent stenosis. First, the trial was reported to be...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2007-03, Vol.356 (10), p.1071-1073 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | To the Editor:
We question the conclusion by Scheller and colleagues (Nov. 16 issue)
1
that paclitaxel-coated balloon catheters significantly reduce the incidence of adverse outcomes in patients undergoing percutaneous coronary intervention for in-stent stenosis. First, the trial was reported to be a double-blind study, but the investigators were aware of assignments to study groups because the paclitaxel-coated balloons were a different color from the uncoated balloons. The reduction in major cardiac events in patients who received treatment with a paclitaxel-coated balloon was driven primarily by a reduction in target-lesion revascularization, a subjective end point that was based on symptoms and . . . |
---|---|
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJMc063527 |